Overview and Scope
Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).
Sizing and Forecast
The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure.
The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection. Major trends in the forecast period include technological advancements, advancements in ai-assisted diagnostics, point-of-care testing (poct) growth, multiplexing capabilities, biomarker discovery and validation.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Segmentation & Regional Insights
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
North America was the largest region in the cardiac biomarkers testing market in 2023. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cardiovascular diseases is expected to boost the growth of the cardiac biomarkers testing market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Cardiac biomarker tests assist in determining the levels of biomarkers to immediately determine the severity of a heart attack and its magnitude. Hence, an increase in the prevalence of cardiovascular diseases will lead to an increase in the demand for cardiac biomarker testing solutions. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, an increase in the prevalence of cardiovascular diseases is driving the growth of the cardiac biomarkers testing market.
Key Industry Players
Major companies operating in the cardiac biomarker testing market are focusing on innovative products such as cardiac biomarkers to drive revenues in their market. Cardiac biomarkers, also known as cardiac enzymes, are substances that are released into the bloodstream when the heart muscle is damaged. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. a China-based company that specializes in the development, manufacture, and distribution of medical equipment and solutions launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn in terms of sensitivity, accuracy, and reliability in identifying myocardial damage. These new products are intended to support improved treatment for cardiovascular illnesses by giving dependable solutions that improve patient outcomes both within and beyond the context of cardiovascular illnesses.
The cardiac biomarkers testing market report table of contents includes:
1. Executive Summary
2. Cardiac Biomarkers Testing Market Characteristics
3. Cardiac Biomarkers Testing Market Trends And Strategies
4. Cardiac Biomarkers Testing Market – Macro Economic Scenario
5. Global Cardiac Biomarkers Testing Market Size and Growth
………………………………
31. Global Cardiac Biomarkers Testing Market Competitive Benchmarking
32. Global Cardiac Biomarkers Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Cardiac Biomarkers Testing Market
34. Cardiac Biomarkers Testing Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
